Literature DB >> 3597864

Pustular psoriasis associated with hydroxychloroquine.

S J Friedman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3597864     DOI： 10.1016/s0190-9622(87)80021-x

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN： 0190-9622            Impact factor:   11.527


× No keyword cloud information.
  6 in total

1.  Drug-provoked psoriasis: is it drug induced or drug aggravated?: understanding pathophysiology and clinical relevance.

Authors:  Grace K Kim; James Q Del Rosso
Journal:  J Clin Aesthet Dermatol       Date:  2010-01

Review 2.  The role of xenobiotics in triggering psoriasis.

Authors:  Jasna Grželj; Marija Sollner Dolenc
Journal:  Arch Toxicol       Date:  2020-08-24       Impact factor: 5.153

3.  Hydroxychloroquine effects on psoriasis: A systematic review and a cautionary note for COVID-19 treatment.

Authors:  Muskaan Sachdeva; Asfandyar Mufti; Khalad Maliyar; Yuliya Lytvyn; Jensen Yeung
Journal:  J Am Acad Dermatol       Date:  2020-05-19       Impact factor: 11.527

4.  Ixekizumab for treatment of refractory acute generalized exanthematous pustulosis caused by hydroxychloroquine.

Authors:  Mohammad Munshi; Alexandra Junge; Karolina Gadaldi; Nikhil Yawalkar; Kristine Heidemeyer
Journal:  JAAD Case Rep       Date:  2020-05-17

5.  A Delphi Consensus Approach to Challenging Case Scenarios in Moderate-to-Severe Psoriasis: Part 1.

Authors:  Bruce E Strober; Jennifer Clay Cather; David Cohen; Jeffrey J Crowley; Kenneth B Gordon; Alice B Gottlieb; Arthur F Kavanaugh; Neil J Korman; Gerald G Krueger; Craig L Leonardi; Sergio Schwartzman; Jeffrey M Sobell; Gary E Solomon; Melodie Young
Journal:  Dermatol Ther (Heidelb)       Date:  2012-03-17

Review 6.  Drug-induced psoriasis: clinical perspectives.

Authors:  Deepak Mw Balak; Enes Hajdarbegovic
Journal:  Psoriasis (Auckl)       Date:  2017-12-07
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.